Difference between revisions of "Team:Calgary"
| Line 13: | Line 13: | ||
margin-top: 180px; | margin-top: 180px; | ||
margin-bottom: 180px; | margin-bottom: 180px; | ||
| − | + | ||
} | } | ||
| Line 28: | Line 28: | ||
p { | p { | ||
text-align: justify; | text-align: justify; | ||
| − | + | font-size: 20px !important; | |
} | } | ||
| − | .info-link { | + | |
| + | .info-link { | ||
padding: 0 !important; | padding: 0 !important; | ||
} | } | ||
| − | |||
| − | |||
| − | |||
| − | a: | + | a:link { |
| − | + | color: #f38f8f; | |
| − | } | + | } |
| − | a:hover { | + | a:visited { |
| − | + | color: #f38f8f; | |
| − | } | + | } |
| + | |||
| + | a:hover { | ||
| + | color: #f38f8f; | ||
| + | } | ||
| + | |||
| + | a:active { | ||
| + | color: #f38f8f; | ||
| + | } | ||
| − | |||
| − | |||
| − | |||
#moving-helix { | #moving-helix { | ||
height: 400px; | height: 400px; | ||
| Line 106: | Line 109: | ||
font-size: 12px; | font-size: 12px; | ||
} | } | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | .wrapper { | |
| + | text-align: center; | ||
| + | } | ||
| + | |||
| + | body {} | ||
@media only screen and (max-width: 1050px) { | @media only screen and (max-width: 1050px) { | ||
| Line 239: | Line 242: | ||
<!-- Page 2 --> | <!-- Page 2 --> | ||
<div class="section"> | <div class="section"> | ||
| − | + | <h1> The ideal medicine is not a perfect treatment - </h1> | |
| − | + | <br> | |
| − | + | <br> | |
| − | + | <h1><b>It’s a cure.</b></h1> | |
| − | + | ||
</div> | </div> | ||
<!-- Page 3 --> | <!-- Page 3 --> | ||
<div class="section"> | <div class="section"> | ||
<div class="row"> | <div class="row"> | ||
| − | + | <div class="col-lg-6 info"> | |
| − | + | <p style="text-align: left"> | |
| − | + | Advancements in genetic modification have opened avenues towards numerous tracks of scientific | |
| − | + | development. In particular, | |
| − | + | the demand for permanent health solutions has sparked massive interest in gene therapy. | |
| − | </p> | + | </p> |
| + | </div> | ||
| + | <div class="col-lg-6 info"> | ||
| + | <p style="text-align: left"> | ||
| + | Despite the potential for establishing an ideal medicine, there are still numerous challenges. | ||
| + | The selection of an integration target site, | ||
| + | methodology pertaining to gene | ||
| + | delivery, and maintenance of gene expression currently limit the potential for gene therapy | ||
| + | to become common practice. | ||
| + | </p> | ||
| + | </div> | ||
</div> | </div> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
</div> | </div> | ||
| Line 270: | Line 273: | ||
<div class="section"> | <div class="section"> | ||
<h1>But how do we overcome these problems?</h1> | <h1>But how do we overcome these problems?</h1> | ||
| − | + | <br><br> | |
<h1 id="home-title">SNIP | <h1 id="home-title">SNIP | ||
| − | + | <span style="color: #7ccfb8">EQUIP</span> FLIP</h1> | |
| − | + | ||
| − | + | <p style="text-align: middle font-size: 20px">The system that allows for the integration and maintenance of | |
| − | + | large-scale genetic | |
| − | + | constructs in eukaryotic systems.</p> | |
| − | + | ||
| + | </div> | ||
<!-- Page 5 --> | <!-- Page 5 --> | ||
| − | |||
<div class="section"> | <div class="section"> | ||
| − | + | <br> | |
| − | + | <div class="row"> | |
| − | + | <div class="col-lg-6 info"> | |
| − | + | <p style="text-align: left"> | |
| − | + | University of Calgary’s Snip, Equip, Flip aims to overcome the aforementioned obstacles. | |
| − | + | This system allows | |
| − | + | for the creation of eukaryotic cell lines via stable integration and expression of exogenous | |
| − | + | genes. | |
| − | + | <br><br> | |
| − | + | A simple and reliable method that can be used by experienced and entrant researchers | |
| − | + | alike that can lead to a vast array of scientific discoveries. | |
| − | </p> | + | </p> |
| + | </div> | ||
| + | <div class="col-lg-6 info"> | ||
| + | <p style="text-align: left"> | ||
| + | By complementing the specificity of targeting that CRISPR/Cas9 offers with the much larger | ||
| + | integration | ||
| + | capabilities of FLP recombinase and beta resolvase, gene integration into eukaryotic genomes | ||
| + | becomes a | ||
| + | simple process of Snip, Equip, Flip. | ||
| + | <br><br> | ||
| + | The expression of integrated genes is then protected and maintained over time by adding | ||
| + | flanking | ||
| + | chromatin modifying elements. | ||
| + | </p> | ||
| + | </div> | ||
</div> | </div> | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
</div> | </div> | ||
<!-- Page 6 --> | <!-- Page 6 --> | ||
<div class="section"> | <div class="section"> | ||
<p style="text-align: left"> | <p style="text-align: left"> | ||
| − | + | <h5> University of Calgary iGEM also introduced novel eukaryotic parts into the iGEM registry | |
| − | + | and successfully built a multi-cloning site. </h5> | |
| − | + | <br> | |
| − | + | <h5>The team has created the following to complement Snip, Equip, Flip and give back to the iGEM | |
| − | + | community: | |
| − | + | </h5> | |
| − | + | <br> | |
| − | + | <div class="row"> | |
| − | + | <div class="col-lg-6 info"> | |
| − | + | <p style="text-align: left"> | |
| − | + | Droplet microfluidic device designed for scalable gene transfer system. | |
| + | <br> | ||
| − | + | </p> | |
| − | + | </div> | |
| − | + | <div class="col-lg-6 info"> | |
| − | + | <p style="text-align: left"> | |
| − | + | SARA, a software tool built for iGEM participants. SARA helps iGEMers find past software | |
| − | + | projects | |
| − | + | for use in their own projects. | |
| − | + | <br> | |
| − | + | </p> | |
| − | + | </div> | |
| − | + | </div> | |
| − | + | <div class="wrapper"> | |
| − | + | <a href="https://2018.igem.org/Team:Calgary/CRISPR"><button type="button" class="btn btn-outline-dark">Our | |
| − | + | System</button></a> | |
| − | + | </div> | |
</div> | </div> | ||
</div> | </div> | ||
Revision as of 21:38, 17 October 2018
SNIP EQUIP FLIP
The ideal medicine is not a perfect treatment -
It’s a cure.
Advancements in genetic modification have opened avenues towards numerous tracks of scientific development. In particular, the demand for permanent health solutions has sparked massive interest in gene therapy.
Despite the potential for establishing an ideal medicine, there are still numerous challenges. The selection of an integration target site, methodology pertaining to gene delivery, and maintenance of gene expression currently limit the potential for gene therapy to become common practice.
But how do we overcome these problems?
SNIP EQUIP FLIP
The system that allows for the integration and maintenance of large-scale genetic constructs in eukaryotic systems.
University of Calgary’s Snip, Equip, Flip aims to overcome the aforementioned obstacles.
This system allows
for the creation of eukaryotic cell lines via stable integration and expression of exogenous
genes.
A simple and reliable method that can be used by experienced and entrant researchers
alike that can lead to a vast array of scientific discoveries.
By complementing the specificity of targeting that CRISPR/Cas9 offers with the much larger
integration
capabilities of FLP recombinase and beta resolvase, gene integration into eukaryotic genomes
becomes a
simple process of Snip, Equip, Flip.
The expression of integrated genes is then protected and maintained over time by adding
flanking
chromatin modifying elements.
University of Calgary iGEM also introduced novel eukaryotic parts into the iGEM registry and successfully built a multi-cloning site.
The team has created the following to complement Snip, Equip, Flip and give back to the iGEM community:
Droplet microfluidic device designed for scalable gene transfer system.
SARA, a software tool built for iGEM participants. SARA helps iGEMers find past software
projects
for use in their own projects.
or scroll